Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The Advertising Standards Authority (ASA) has ruled against several weight-loss patches in recent years for unsubstantiated efficacy claims, including specific rulings in 2020, 2022 and 2023 on slimming patches that promised appetite suppression or fat-burning effects
This trend aligns with national dispensing patterns, where a study reported a nearly 600% increase in GLP-1 RA prescription fills among adolescents and young adults from 2020 to 2023 ( 9 ) and our own research, which has shown that GLP-1 RAs now make up over 5% of all prescriptions prescribed
This allows semaglutide to be administered once weekly for sustained therapeutic effects, whereas natural GLP-1 functions only as a brief meal-related signal
Theyre used to treat deficiency
